These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 20600224)

  • 1. Tetracycline and penicillin resistant Clostridium perfringens isolated from the fangs and venom glands of Loxosceles laeta: its implications in loxoscelism treatment.
    Catalán A; Espoz MC; Cortés W; Sagua H; González J; Araya JE
    Toxicon; 2010 Nov; 56(6):890-6. PubMed ID: 20600224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and identification of Clostridium perfringens in the venom and fangs of Loxosceles intermedia (brown spider): enhancement of the dermonecrotic lesion in loxoscelism.
    Monteiro CL; Rubel R; Cogo LL; Mangili OC; Gremski W; Veiga SS
    Toxicon; 2002 Apr; 40(4):409-18. PubMed ID: 11738234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the venom from the Brazilian Brown Spider Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae).
    Silvestre FG; de Castro CS; de Moura JF; Giusta MS; De Maria M; Alvares ES; Lobato FC; Assis RA; Gonçalves LA; Gubert IC; Chávez-Olórtegui C; Kalapothakis E
    Toxicon; 2005 Dec; 46(8):927-36. PubMed ID: 16289643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation.
    de Oliveira KC; Gonçalves de Andrade RM; Piazza RM; Ferreira JM; van den Berg CW; Tambourgi DV
    Toxicon; 2005 Mar; 45(4):421-9. PubMed ID: 15733563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia).
    Pauli I; Minozzo JC; da Silva PH; Chaim OM; Veiga SS
    Toxicon; 2009 May; 53(6):660-71. PubMed ID: 19673081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
    Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
    Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
    Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
    Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom.
    de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC
    J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingomyelinase D from Loxosceles laeta Venom Induces the Expression of MMP7 in Human Keratinocytes: Contribution to Dermonecrosis.
    Corrêa MA; Okamoto CK; Gonçalves-de-Andrade RM; van den Berg CW; Tambourgi DV
    PLoS One; 2016; 11(4):e0153090. PubMed ID: 27078876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of Swedish, Norwegian and Danish isolates of Clostridium perfringens from poultry, and distribution of tetracycline resistance genes.
    Johansson A; Greko C; Engström BE; Karlsson M
    Vet Microbiol; 2004 Apr; 99(3-4):251-7. PubMed ID: 15066727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning, expression, function and immunoreactivities of members of a gene family of sphingomyelinases from Loxosceles venom glands.
    Tambourgi DV; de F Fernandes Pedrosa M; van den Berg CW; Gonçalves-de-Andrade RM; Ferracini M; Paixão-Cavalcante D; Morgan BP; Rushmere NK
    Mol Immunol; 2004 Jul; 41(8):831-40. PubMed ID: 15234562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials.
    de Almeida DM; Fernandes-Pedrosa Mde F; de Andrade RM; Marcelino JR; Gondo-Higashi H; de Azevedo Ide L; Ho PL; van den Berg C; Tambourgi DV
    Am J Trop Med Hyg; 2008 Sep; 79(3):463-70. PubMed ID: 18784245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astacin-like metalloproteases are a gene family of toxins present in the venom of different species of the brown spider (genus Loxosceles).
    Trevisan-Silva D; Gremski LH; Chaim OM; da Silveira RB; Meissner GO; Mangili OC; Barbaro KC; Gremski W; Veiga SS; Senff-Ribeiro A
    Biochimie; 2010 Jan; 92(1):21-32. PubMed ID: 19879318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.
    Felicori L; Araujo SC; de Avila RA; Sanchez EF; Granier C; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2006 Oct; 48(5):509-19. PubMed ID: 16934304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brown spiders and loxoscelism.
    da Silva PH; da Silveira RB; Appel MH; Mangili OC; Gremski W; Veiga SS
    Toxicon; 2004 Dec; 44(7):693-709. PubMed ID: 15500846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brown spider dermonecrotic toxin directly induces nephrotoxicity.
    Chaim OM; Sade YB; da Silveira RB; Toma L; Kalapothakis E; Chávez-Olórtegui C; Mangili OC; Gremski W; von Dietrich CP; Nader HB; Sanches Veiga S
    Toxicol Appl Pharmacol; 2006 Feb; 211(1):64-77. PubMed ID: 16005484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetracycline protects against dermonecrosis induced by Loxosceles spider venom.
    Paixão-Cavalcante D; van den Berg CW; Gonçalves-de-Andrade RM; Fernandes-Pedrosa Mde F; Okamoto CK; Tambourgi DV
    J Invest Dermatol; 2007 Jun; 127(6):1410-8. PubMed ID: 17218940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
    de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
    Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal anti-loxosceles Fab fragments attenuate dermonecrotic arachnidism.
    Gomez HF; Miller MJ; Trachy JW; Marks RM; Warren JS
    Acad Emerg Med; 1999 Dec; 6(12):1195-202. PubMed ID: 10609920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and genotypic characterization of tetracycline and minocycline resistance in Clostridium perfringens.
    Park M; Rooney AP; Hecht DW; Li J; McClane BA; Nayak R; Paine DD; Rafii F
    Arch Microbiol; 2010 Oct; 192(10):803-10. PubMed ID: 20661548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.